Waste disposal-An attractive strategy for cancer therapy

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Targeted cancer therapies often involve small molecules or antibodies inhibiting specific proteins driving tumor growth.
• Tumor cells frequently develop resistance to these therapies, limiting treatment durability.
• Many oncogenic proteins lack druggable enzymatic or receptor activities, posing a challenge for conventional targeted therapy.

Purpose of the Study:

• To present an alternative targeted therapy strategy.
• To leverage the ubiquitin-proteasome system for selective degradation of cancer-causing proteins.
• To review existing protein-degrading drugs and recent advancements in designing novel small molecules for targeted protein degradation.

Main Methods:

• Review of existing cancer drugs that induce protein degradation.
• Discussion of recent progress in rational design of small molecules.
• Preclinical testing of small molecules for selective target protein degradation.

Main Results:

• Identification of existing drugs that utilize protein degradation pathways.
• Advancements in the design of small molecules that induce selective degradation of target proteins.
• Preclinical validation of novel targeted protein degradation strategies.

Conclusions:

• Co-opting the ubiquitin-proteasome system offers a promising alternative to conventional targeted cancer therapy.
• This approach can overcome drug resistance and target proteins previously considered undruggable.
• Rational design of small molecules is advancing the field of targeted protein degradation for cancer treatment.